Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Dose Escalation”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT02335918
What this trial is testing

A Dose Escalation and Cohort Expansion Study of Anti-CD27 (Varlilumab) and Anti-PD-1 (Nivolumab) in Advanced Refractory Solid Tumors

Who this might be right for
Squamous Cell Carcinoma of the Head and Neck (SCCHN)Ovarian Carcinoma-Enrollment CompletedColorectal Cancer (CRC)-Enrollment Completed+2 more
Celldex Therapeutics 175
Early research (Phase 1)Study completedNCT00848510
What this trial is testing

EMD 525797 in Colorectal and Ovarian Cancer Patients With Liver Metastases

Who this might be right for
Colorectal and Ovarian Cancer Patients With Liver Metastases
Merck KGaA, Darmstadt, Germany 41
Early research (Phase 1)Study completedNCT00724997
What this trial is testing

Randomized, Double-blind, Placebo-controlled, Phase I Dose-escalation Study of Single Dose GHB01L1 in Healthy Volunteers

Who this might be right for
Seasonal Human Influenza
AVIR Green Hills Biotechnology AG 48
Early research (Phase 1)Study completedNCT01170897
What this trial is testing

Study of PEGPH20 With Initial Dexamethasone Premedication Given Intravenously to Patients With Advanced Solid Tumors

Who this might be right for
Solid Tumor
Halozyme Therapeutics 27
Early research (Phase 1)Study completedNCT05324410
What this trial is testing

Dose Escalation Study to Evaluate Safety and Pharmacokinetics (PK) of VX-840 in Healthy Participants

Who this might be right for
APOL1-mediated Kidney Disease
Vertex Pharmaceuticals Incorporated 88
Testing effectiveness (Phase 2)WithdrawnNCT04243941
What this trial is testing

PSMA-PET/MRI Low- and Intermediate-Risk Prostate Cancer

Who this might be right for
Prostate Cancer
UNC Lineberger Comprehensive Cancer Center
Early research (Phase 1)Active Not RecruitingNCT03283137
What this trial is testing

Combination of Pembrolizumab With TGR-1202 in Patients With Relapsed/Refractory CLL and B-cell NHL

Who this might be right for
CLLB-cell Non Hodgkin Lymphoma
University of Chicago 20
Early research (Phase 1)Study completedNCT01703572
What this trial is testing

A Dose Escalation Study of OMP-52M51 in Subjects With Lymphoid Malignancies

Who this might be right for
Relapsed or Refractory Lymphoid Malignancies
OncoMed Pharmaceuticals, Inc. 24
Testing effectiveness (Phase 2)Ended earlyNCT03340883
What this trial is testing

Safety and Tolerability of BION-1301 in Adults With Relapsed or Refractory Multiple Myeloma (MM)

Who this might be right for
Multiple Myeloma
Chinook Therapeutics, Inc. 21
Testing effectiveness (Phase 2)Ended earlyNCT00907166
What this trial is testing

A Phase I/II Open-Label Dose-Escalation Clinical Trial of CPI-613 in Combination With Gemcitabine in Cancer Patients

Who this might be right for
CancerPancreatic CancerPancreatic Carcinoma
Cornerstone Pharmaceuticals 6
Early research (Phase 1)Study completedNCT07095231
What this trial is testing

Safety, Reactogenicity, and Immunogenicity Trial of STX-S SARS-CoV-2 Vaccine in Adults

Who this might be right for
COVID-19
National Institute of Allergy and Infectious Diseases (NIAID) 60
Testing effectiveness (Phase 2)Study completedNCT00002602
What this trial is testing

Radiation Therapy in Treating Patients With Stage II or Stage III Prostate Cancer

Who this might be right for
Prostate Cancer
Radiation Therapy Oncology Group 1,084
Early research (Phase 1)Study completedNCT05277402
What this trial is testing

ADG116 in Combination With Pembrolizumab in Patients With Advanced/Metastatic Solid Tumors

Who this might be right for
Advanced/Metastatic Solid Tumors
Adagene Inc 6
Early research (Phase 1)Ended earlyNCT05061537
What this trial is testing

Study of PF-07263689 in Participants With Selected Advanced Solid Tumors

Who this might be right for
Renal Cell CancerMelanomaNon-Small-Cell Lung Cancer+7 more
Pfizer 13
Early research (Phase 1)Study completedNCT03733951
What this trial is testing

KN046 in Subjects With Advanced Solid Tumors and Lymphoma

Who this might be right for
Advanced Solid TumorsLymphoma
Jiangsu Alphamab Biopharmaceuticals Co., Ltd 139
Early research (Phase 1)Study completedNCT01093729
What this trial is testing

HM11260C in Healthy Male Subject

Who this might be right for
Healthy
Hanmi Pharmaceutical Company Limited 41
Early research (Phase 1)Study completedNCT01577953
What this trial is testing

Safety, Tolerability, and Pharmacokinetics After a Single Dose of Orally Inhaled DNAzyme Solution for Nebulisation in Male Patients With Asthma

Who this might be right for
Asthma
Sterna Biologicals GmbH & Co. KG 24
Early research (Phase 1)Study completedNCT01966445
What this trial is testing

Dose Escalation Study to Investigate the Safety, Pharmacokinetics, and Pharmacodynamics of GSK2849330 in Subjects With Advanced Her3-Positive Solid Tumors

Who this might be right for
CancerNeoplasms
GlaxoSmithKline 29
Testing effectiveness (Phase 2)Study completedNCT00742963
What this trial is testing

Dose-Escalation Study of TH-302 in Combination With Doxorubicin to Treat Patients With Advanced Soft Tissue Sarcoma

Who this might be right for
Soft Tissue Sarcoma
ImmunoGenesis 107
Early research (Phase 1)Study completedNCT02192021
What this trial is testing

Micro Needle Array-Doxorubicin (MNA-D) in Patients With Cutaneous T-cell Lymphoma (CTCL)

Who this might be right for
Cutaneous T Cell Lymphoma
Falo, Louis, MD 20
Next Page